Iris K Minichmayr

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Cerebrospinal Fluid

Intensive Care Unit

Metastatic Colorectal Cancer

Top Venues

Clinical pharmacology and therapeutics

Paediatric drugs

Therapeutic drug monitoring

Clinical pharmacokinetics

This page only lists publications with an associated author ORCID identifier.

Publications

Iris K Minichmayr, Tomoyuki Mizuno, Srijib Goswami, Richard Wilson Peck, Thomas M Polasek, null null
Recent Advances Addressing the Challenges of Precision Dosing. Clinical pharmacology and therapeutics 116 (3) (2024)
Dahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, Rani Soenen, Zohra Layegh, Murray L Barclay, Tomoyuki Mizuno, Iris K Minichmayr, Ron J Keizer, Sebastian Georg Wicha, Gerrit J Wolbink, Jo Lydie Wilfried Lambert, Severine Vermeire, Annick de Vries, Konstantinos Papamichael, Núria Padullés-Zamora, Erwin Dreesen
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic drug monitoring 46 (3) (2024)
Iris K Minichmayr, Ursula Knaack, Johannes Gojo, Daniel Senfter, Christine Haberler, Amedeo A Azizi, Lisa Mayr, Markus Zeitlinger, Andreas Peyrl
Distribution of Bevacizumab into the Cerebrospinal Fluid of Children and Adolescents with Recurrent Brain Tumors. Paediatric drugs (2024)
Iris K Minichmayr, Tomoyuki Mizuno, Srijib Goswami, Richard Wilson Peck, Thomas M Polasek, null null
Recent Advances Addressing the Challenges of Precision Dosing. Clinical pharmacology and therapeutics (2024)
Iris K Minichmayr, Ursula Knaack, Johannes Gojo, Daniel Senfter, Christine Haberler, Amedeo A Azizi, Lisa Mayr, Markus Zeitlinger, Andreas Peyrl
Distribution of Bevacizumab into the Cerebrospinal Fluid of Children and Adolescents with Recurrent Brain Tumors. Paediatric drugs 26 (4) (2024)
Dahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, Rani Soenen, Zohra Layegh, Murray L Barclay, Tomoyuki Mizuno, Iris K Minichmayr, Ron J Keizer, Sebastian Georg Wicha, Gerrit J Wolbink, Jo Lydie Wilfried Lambert, Severine Vermeire, Annick de Vries, Konstantinos Papamichael, Núria Padullés-Zamora, Erwin Dreesen
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic drug monitoring 46 (3) (2024)
Iris K Minichmayr, Ursula Knaack, Johannes Gojo, Daniel Senfter, Christine Haberler, Amedeo A Azizi, Lisa Mayr, Markus Zeitlinger, Andreas Peyrl
Distribution of Bevacizumab into the Cerebrospinal Fluid of Children and Adolescents with Recurrent Brain Tumors. Paediatric drugs 26 (4) (2024)
Iris K Minichmayr, Mohamad Shebley, Piet H van der Graaf, Karthik Venkatakrishnan
Getting the Dosage Right: A Vital Role for Clinical Pharmacology in the Era of Precision Medicine. Clinical pharmacology and therapeutics 116 (3) (2024)
Iris K Minichmayr, Ursula Knaack, Johannes Gojo, Daniel Senfter, Christine Haberler, Amedeo A Azizi, Lisa Mayr, Markus Zeitlinger, Andreas Peyrl
Distribution of Bevacizumab into the Cerebrospinal Fluid of Children and Adolescents with Recurrent Brain Tumors. Paediatric drugs 26 (4) (2024)
Dahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, Rani Soenen, Zohra Layegh, Murray L Barclay, Tomoyuki Mizuno, Iris K Minichmayr, Ron J Keizer, Sebastian Georg Wicha, Gerrit J Wolbink, Jo Lydie Wilfried Lambert, Severine Vermeire, Annick de Vries, Konstantinos Papamichael, Núria Padullés-Zamora, Erwin Dreesen
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic drug monitoring (2024)
D Max Smith, Iris K Minichmayr, Joseph F Standing, Kathleen M Giacomini, Piet H van der Graaf, Richard Wilson Peck
Ensuring Transparency and Quality of Clinical Trial Reporting in Clinical Pharmacology & Therapeutics: Prospective Trial Registration and Compliance with Reporting Guidelines Are Required for all Clinical Trials. Clinical pharmacology and therapeutics 114 (6) (2023)
Iris K Minichmayr, D Max Smith, Kathleen M Giacomini, Piet H van der Graaf
Trends in Clinical Pharmacology and Therapeutics. Clinical pharmacology and therapeutics 114 (1) (2023)
Iris K Minichmayr, Sebastian Georg Wicha, Peter Matzneller, Charlotte Kloft, Markus Zeitlinger
Impact of Key Components of Intensified Ceftaroline Dosing on Pharmacokinetic/Pharmacodynamic Target Attainment. Clinical pharmacokinetics (2023)
Iris K Minichmayr, Markus Zeitlinger
Comment on "Target-Controlled Continuous Infusion for Antibiotic Dosing: Proof-of-Principle in an In-silico Vancomycin Trial in Intensive Care Unit Patients". Clinical pharmacokinetics 58 (7) (2020)